Plant Details English Sub Title
A great proportion of the credit for the exponential growth of Al Andalous can be attributed to its Research and development department. Our R&D department is committed to producing superior generic versions of brand-name medicines to meet Egyptian and export requirements. To achieve this goal, our team’s dedication to quality is uncompromising. As great products start with great minds, R&D team comprises a group of highly trained pharmacists in research and development activities including pharmaceutical development, analytical method development and validation, stability studies and comparative dissolution and bioequivalence department. From working with raw materials with only the finest specifications to performing experiments using the latest scientific approaches, R&D team ensures the production of safe and effective pharmaceuticals with a premium quality.
QMS IS DESIGNED TO meet cGMP requirements and ISO 9001:2015, ISO 14001:2015 and ISO 45001: 2018 standards and international standards (WHO and EMA) to ensure that all our products are consistently produced and controlled to the highest up-to-date national and international standards. Al-Andalous management is committed to continuously improving through implementing periodical &. systematic c GMP monitoring and rigorous training programs.
QMS in Al Andalous was established to: -
To attain these objectives, a comprehensively designed &. strictly implemented quality assurance system incorporating all aspects of cGMP is in place. Achievement of these objectives is the responsibility of all employees in all departments &. at all levels within Al-Andalous and its stakeholders.